Evidence map›Paper›PMID 30696847›Full record

ArticleScientific reports2019

Nanoparticle administration method in cell culture alters particle-cell interaction.

Thomas L Moore, Dominic A Urban, Laura Rodriguez-Lorenzo, Ana Milosevic, Federica Crippa, Miguel Spuch-Calvar, Sandor Balog, Barbara Rothen-Rutishauser, Marco Lattuada, Alke Petri-Fink

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions.Small (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Thomas L MooreAdolphe Merkle Institute, Université de Fribourg, Fribourg, 1700, Switzerland.ORCID 0000-0002-7886-5245
Dominic A UrbanAdolphe Merkle Institute, Université de Fribourg, Fribourg, 1700, Switzerland.
Laura Rodriguez-LorenzoAdolphe Merkle Institute, Université de Fribourg, Fribourg, 1700, Switzerland.
Ana MilosevicAdolphe Merkle Institute, Université de Fribourg, Fribourg, 1700, Switzerland.
Federica CrippaAdolphe Merkle Institute, Université de Fribourg, Fribourg, 1700, Switzerland.
Miguel Spuch-CalvarAdolphe Merkle Institute, Université de Fribourg, Fribourg, 1700, Switzerland.
Sandor BalogAdolphe Merkle Institute, Université de Fribourg, Fribourg, 1700, Switzerland.ORCID 0000-0002-4847-9845
Barbara Rothen-RutishauserAdolphe Merkle Institute, Université de Fribourg, Fribourg, 1700, Switzerland.ORCID 0000-0002-7805-9366
Marco LattuadaChemistry Department, Université de Fribourg, Fribourg, 1700, Switzerland.
Alke Petri-FinkAdolphe Merkle Institute, Université de Fribourg, Fribourg, 1700, Switzerland. alke.fink@unifr.ch.
University of Fribourg · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a highly interdisciplinary field, working with nanoparticles in a biomedical context requires a robust understanding of soft matter physics, colloidal behaviors, nano-characterization methods, biology, and bio-nano interactions. When reporting results, it can be easy to overlook simple, seemingly trivial experimental details. In this context, we set out to understand how in vitro technique, specifically the way we administer particles in 2D culture, can influence experimental outcomes. Gold nanoparticles coated with poly(vinylpyrrolidone) were added to J774A.1 mouse monocyte/macrophage cultures as either a concentrated bolus, a bolus then mixed via aspiration, or pre-mixed in cell culture media. Particle-cell interaction was monitored via inductively coupled plasma-optical emission spectroscopy and we found that particles administered in a concentrated dose interacted more with cells compared to the pre-mixed administration method. Spectroscopy studies reveal that the initial formation of the protein corona upon introduction to cell culture media may be responsible for the differences in particle-cell interaction. Modeling of particle deposition using the in vitro sedimentation, diffusion and dosimetry model helped to clarify what particle phenomena may be occurring at the cellular interface. We found that particle administration method in vitro has an effect on particle-cell interactions (i.e. cellular adsorption and uptake). Initial introduction of particles in to complex biological media has a lasting effect on the formation of the protein corona, which in turn mediates particle-cell interaction. It is of note that a minor detail, the way in which we administer particles in cell culture, can have a significant effect on what we observe regarding particle interactions in vitro.

Indexed as

Cell Culture TechniquesNanoparticlesBiological TransportGoldHumansMacrophagesMetal NanoparticlesMicroscopy, FluorescenceGold

Identifiers

PMID30696847
PMCPMC6351679
OpenAlexW2913733119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.